Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that its TVC Imaging System(TM) for the true vessel characterization of coronary artery disease will be featured in panels, live case presentations and a plenary session at EuroPCR 2012, being held May 15-18, 2012 at the Palais des Congres in Paris.
Read entire article: http://www.marketwatch.com/story/infraredx-announces-tvc-imaging-system-to-be-featured-in-panels-live-case-broadcasts-and-plenary-session-at-europcr-2012-2012-05-10
Loading...
Share